<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>MFM Rounds</title>
    <link>https://rauscha.github.io/Dialog-podcast</link>
    <description>A weekly peer-level digest of the most important new maternal-fetal medicine research, with Juno and Caspar.</description>
    <language>en</language>
    <itunes:author>Juno &amp; Caspar</itunes:author>
    <itunes:category text="Science">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <itunes:explicit>false</itunes:explicit>
    <itunes:owner>
      <itunes:name>Juno &amp; Caspar</itunes:name>
      <itunes:email>podcast@andrewrausch.com</itunes:email>
    </itunes:owner>
    <itunes:image href="https://rauscha.github.io/Dialog-podcast/assets/cover-mfm.jpg"/>
    <atom:link href="https://rauscha.github.io/Dialog-podcast/feed-mfm.xml" rel="self" type="application/rss+xml"/>
        <item>
      <title>Screening Chronic Hypertension Before Aspirin</title>
      <description><![CDATA[Here&apos;s the version of this I&apos;ve done a hundred times. Chronic hypertensive, first visit, eleven weeks. You write the aspirin. You move on. History is the indication, drug is cheap, harm profile is essentially nothing. What&apos;s the argument against just doing that?
The argument isn&apos;t against the aspirin. It&apos;s against treating the aspirin as the end of the decision. The empiric reflex gets her the drug. It doesn&apos;t tell you whether she&apos;s in the s...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=0">0:00</a> — Cold Open: The Empiric Reflex</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=61">1:02</a> — Headline Setup: Who&apos;s in the Room</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=123">2:04</a> — Headline Deep Dive: Effect Size and What It Means</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=185">3:05</a> — Round 1: Proteinuria Severity and Long-Term Cardiorenal Risk (BJOG)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=247">4:07</a> — Round 2: Semaglutide Into Pregnancy (Green Journal)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=309">5:09</a> — Round 3: 22-Week Survival and the Intervention Bundle (AJOG MFM)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=370">6:11</a> — Round 4: FMF Calibration Across Conception Modes (Ultrasound Obstet Gynecol)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=432">7:13</a> — What to Watch / Still Unsettled</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=494">8:14</a> — Sign-Off</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1002/uog.70212">First-trimester prediction and prevention of preterm pre-eclampsia in women with chronic hypertension.</a> - Provides RCT-level evidence that biomarker-driven first-trimester screening and aspirin prophylaxis delay preterm preeclampsia in chronic hypertensives—directly informing whether to screen universally or treat empirically.</li><li><a href="https://doi.org/10.1097/aog.0000000000006325">Gestational Weight Gain and Pregnancy Outcomes After Semaglutide Exposure.</a> - First large propensity-matched EMR analysis linking ongoing semaglutide use into pregnancy with adverse outcomes, sharpening preconception counseling for patients on GLP-1 agonists.</li><li><a href="https://doi.org/10.1111/1471-0528.70265">Proteinuria in Preeclampsia and Long-Term Risk of Maternal Kidney and Cardiovascular Disease: A Population-Based Cohort Study.</a> - Quantifies how proteinuria severity at preeclampsia diagnosis predicts decades-long maternal cardiorenal risk, enabling more individualized postpartum surveillance.</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.101989">Improving 1-Year Survival at 22 Weeks Gestation: Which Perinatal Interventions Matter?</a> - Identifies specific interventions—steroids, ventilation, surfactant—that independently improve one-year survival at 22 weeks, strengthening evidence-based periviability counseling.</li><li><a href="https://doi.org/10.1002/uog.70244">Predictive performance of Fetal Medicine Foundation first-trimester screening algorithm for pre-eclampsia according to conception mode.</a> - Demonstrates that FMF preeclampsia screening calibration varies by ART versus spontaneous conception, prompting context-specific interpretation in fertility-treatment pregnancies.</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[Here&apos;s the version of this I&apos;ve done a hundred times. Chronic hypertensive, first visit, eleven weeks. You write the aspirin. You move on. History is the indication, drug is cheap, harm profile is essentially nothing. What&apos;s the argument against just doing that?
The argument isn&apos;t against the aspirin. It&apos;s against treating the aspirin as the end of the decision. The empiric reflex gets her the drug. It doesn&apos;t tell you whether she&apos;s in the s...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=0">0:00</a> — Cold Open: The Empiric Reflex</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=61">1:02</a> — Headline Setup: Who&apos;s in the Room</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=123">2:04</a> — Headline Deep Dive: Effect Size and What It Means</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=185">3:05</a> — Round 1: Proteinuria Severity and Long-Term Cardiorenal Risk (BJOG)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=247">4:07</a> — Round 2: Semaglutide Into Pregnancy (Green Journal)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=309">5:09</a> — Round 3: 22-Week Survival and the Intervention Bundle (AJOG MFM)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=370">6:11</a> — Round 4: FMF Calibration Across Conception Modes (Ultrasound Obstet Gynecol)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=432">7:13</a> — What to Watch / Still Unsettled</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3#t=494">8:14</a> — Sign-Off</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1002/uog.70212">First-trimester prediction and prevention of preterm pre-eclampsia in women with chronic hypertension.</a> - Provides RCT-level evidence that biomarker-driven first-trimester screening and aspirin prophylaxis delay preterm preeclampsia in chronic hypertensives—directly informing whether to screen universally or treat empirically.</li><li><a href="https://doi.org/10.1097/aog.0000000000006325">Gestational Weight Gain and Pregnancy Outcomes After Semaglutide Exposure.</a> - First large propensity-matched EMR analysis linking ongoing semaglutide use into pregnancy with adverse outcomes, sharpening preconception counseling for patients on GLP-1 agonists.</li><li><a href="https://doi.org/10.1111/1471-0528.70265">Proteinuria in Preeclampsia and Long-Term Risk of Maternal Kidney and Cardiovascular Disease: A Population-Based Cohort Study.</a> - Quantifies how proteinuria severity at preeclampsia diagnosis predicts decades-long maternal cardiorenal risk, enabling more individualized postpartum surveillance.</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.101989">Improving 1-Year Survival at 22 Weeks Gestation: Which Perinatal Interventions Matter?</a> - Identifies specific interventions—steroids, ventilation, surfactant—that independently improve one-year survival at 22 weeks, strengthening evidence-based periviability counseling.</li><li><a href="https://doi.org/10.1002/uog.70244">Predictive performance of Fetal Medicine Foundation first-trimester screening algorithm for pre-eclampsia according to conception mode.</a> - Demonstrates that FMF preeclampsia screening calibration varies by ART versus spontaneous conception, prompting context-specific interpretation in fertility-treatment pregnancies.</li></ul><br><br><strong>Sources:</strong><ul><li>First-trimester prediction and prevention of preterm pre-eclampsia in women with chronic hypertension. - Ultrasound Obstet Gynecol - 2026 (https://doi.org/10.1002/uog.70212)</li><li>Gestational Weight Gain and Pregnancy Outcomes After Semaglutide Exposure. - Obstet Gynecol - 2026 (https://doi.org/10.1097/aog.0000000000006325)</li><li>Proteinuria in Preeclampsia and Long-Term Risk of Maternal Kidney and Cardiovascular Disease: A Population-Based Cohort Study. - BJOG - 2026 (https://doi.org/10.1111/1471-0528.70265)</li><li>Improving 1-Year Survival at 22 Weeks Gestation: Which Perinatal Interventions Matter? - Am J Obstet Gynecol MFM - 2026 (https://doi.org/10.1016/j.ajogmf.2026.101989)</li><li>Predictive performance of Fetal Medicine Foundation first-trimester screening algorithm for pre-eclampsia according to conception mode. - Ultrasound Obstet Gynecol - 2026 (https://doi.org/10.1002/uog.70244)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Tue, 02 Jun 2026 01:48:04 +0000</pubDate>
      <guid isPermaLink="false">d117a53269b5f78dc6ab1bfdf91d7f96d0f38351d807ac44114974a9f59bf1f3</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.mp3" length="14430919" type="audio/mpeg"/>
      <itunes:duration>10:01</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260601_203813_mfm_rounds_-_week_of_2026_06_02.chapters.json" type="application/json+chapters"/>
    </item>
      <item>
      <title>Preterm Birth and the Decades After</title>
      <description><![CDATA[The reason long-term maternal cardiovascular data after preterm birth has been so thin is follow-up. Most obstetric cohorts don&apos;t run long enough to accumulate mortality events. Registry linkage solves that — population scale, mortality ascertainment, the follow-up horizon you actually need. This week someone had all three.
Smaller signals have been pointing this direction for a decade. The question was always whether the effect size held at scale or whether it wa...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=0">0:00</a> — Cold Open: The Surveillance Gap</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=51">0:52</a> — Headline: Design and Population</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=103">1:44</a> — Headline: Effect Size and the Gestational Age Gradient</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=155">2:36</a> — Headline: Confounding, Causation, and the Shared Risk Factor Problem</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=207">3:27</a> — Headline: Practice Impact and What Remains Unsettled</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=259">4:19</a> — Round 1: Nakaki / Fetal Brain MRI</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=311">5:11</a> — Round 2: Mari / TTTS Expert Synthesis</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=363">6:03</a> — Round 3: Shrestha / Metformin Effect Modification</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=414">6:55</a> — Round 4: Sorrenti / sFGR Diagnostic Criteria</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=466">7:47</a> — Close: What to Watch, What Is Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1111/1471-0528.70273">Spontaneous Preterm Birth and Subsequent Cardiovascular Mortality: Linked Registry Cohort Study</a> - Large population cohort demonstrating 2-3x higher cardiovascular mortality after sPTB, supporting long-term CV surveillance</li><li><a href="https://doi.org/10.1002/uog.70214">Effects of Mediterranean diet and stress-reduction interventions during pregnancy on fetal brain development detected using magnetic resonance imaging</a> - RCT substudy showing detectable fetal brain MRI differences with lifestyle intervention, though small sample limits conclusions</li><li><a href="https://doi.org/10.1016/j.ajog.2026.05.021">Twin-Twin Transfusion Syndrome and Related Monochorionic Disorders: Historical Perspectives, Current Controversies, and Evidence-Based Opportunities</a> - Authoritative synthesis of TTTS diagnostic variability, staging controversies, and laser therapy evidence</li><li><a href="https://doi.org/10.1016/j.ajog.2026.04.043">The effect of metformin on perinatal outcomes in pregnant women with type 2 diabetes differs by baseline insulin requirements</a> - Secondary RCT analysis suggesting metformin benefit varies by insulin requirements, potentially guiding personalized T2D management</li><li><a href="https://doi.org/10.1002/uog.70239">Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction: ISUOG vs Delphi diagnostic criteria</a> - 24-year cohort showing Delphi sFGR criteria better predict adverse outcomes than ISUOG definition in MCDA twins</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[The reason long-term maternal cardiovascular data after preterm birth has been so thin is follow-up. Most obstetric cohorts don&apos;t run long enough to accumulate mortality events. Registry linkage solves that — population scale, mortality ascertainment, the follow-up horizon you actually need. This week someone had all three.
Smaller signals have been pointing this direction for a decade. The question was always whether the effect size held at scale or whether it wa...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=0">0:00</a> — Cold Open: The Surveillance Gap</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=51">0:52</a> — Headline: Design and Population</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=103">1:44</a> — Headline: Effect Size and the Gestational Age Gradient</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=155">2:36</a> — Headline: Confounding, Causation, and the Shared Risk Factor Problem</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=207">3:27</a> — Headline: Practice Impact and What Remains Unsettled</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=259">4:19</a> — Round 1: Nakaki / Fetal Brain MRI</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=311">5:11</a> — Round 2: Mari / TTTS Expert Synthesis</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=363">6:03</a> — Round 3: Shrestha / Metformin Effect Modification</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=414">6:55</a> — Round 4: Sorrenti / sFGR Diagnostic Criteria</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3#t=466">7:47</a> — Close: What to Watch, What Is Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1111/1471-0528.70273">Spontaneous Preterm Birth and Subsequent Cardiovascular Mortality: Linked Registry Cohort Study</a> - Large population cohort demonstrating 2-3x higher cardiovascular mortality after sPTB, supporting long-term CV surveillance</li><li><a href="https://doi.org/10.1002/uog.70214">Effects of Mediterranean diet and stress-reduction interventions during pregnancy on fetal brain development detected using magnetic resonance imaging</a> - RCT substudy showing detectable fetal brain MRI differences with lifestyle intervention, though small sample limits conclusions</li><li><a href="https://doi.org/10.1016/j.ajog.2026.05.021">Twin-Twin Transfusion Syndrome and Related Monochorionic Disorders: Historical Perspectives, Current Controversies, and Evidence-Based Opportunities</a> - Authoritative synthesis of TTTS diagnostic variability, staging controversies, and laser therapy evidence</li><li><a href="https://doi.org/10.1016/j.ajog.2026.04.043">The effect of metformin on perinatal outcomes in pregnant women with type 2 diabetes differs by baseline insulin requirements</a> - Secondary RCT analysis suggesting metformin benefit varies by insulin requirements, potentially guiding personalized T2D management</li><li><a href="https://doi.org/10.1002/uog.70239">Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction: ISUOG vs Delphi diagnostic criteria</a> - 24-year cohort showing Delphi sFGR criteria better predict adverse outcomes than ISUOG definition in MCDA twins</li></ul><br><br><strong>Sources:</strong><ul><li>Welters et al. - BJOG - 2026 - Spontaneous Preterm Birth and Subsequent Cardiovascular Mortality: Linked Registry Cohort Study (https://doi.org/10.1111/1471-0528.70273)</li><li>Nakaki et al. - Ultrasound Obstet Gynecol - 2026 - Effects of Mediterranean diet and stress-reduction interventions during pregnancy on fetal brain development detected using magnetic resonance imaging (https://doi.org/10.1002/uog.70214)</li><li>Mari et al. - Am J Obstet Gynecol - 2026 - Twin-Twin Transfusion Syndrome and Related Monochorionic Disorders: Historical Perspectives, Current Controversies, and Evidence-Based Opportunities (https://doi.org/10.1016/j.ajog.2026.05.021)</li><li>Shrestha et al. - Am J Obstet Gynecol - 2026 - The effect of metformin on perinatal outcomes in pregnant women with type 2 diabetes differs by baseline insulin requirements (https://doi.org/10.1016/j.ajog.2026.04.043)</li><li>Sorrenti et al. - Ultrasound Obstet Gynecol - 2026 - Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction: ISUOG vs Delphi diagnostic criteria (https://doi.org/10.1002/uog.70239)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Wed, 03 Jun 2026 05:39:39 +0000</pubDate>
      <guid isPermaLink="false">4c690c5a60bfe5dda48d6a35b7f241af40dc65ab8b2642024c61504cf2294cdf</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.mp3" length="13528128" type="audio/mpeg"/>
      <itunes:duration>9:24</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260603_003154_mfm_rounds_-_week_of_2026_06_03.chapters.json" type="application/json+chapters"/>
    </item>
  <item>
      <title>When Sequencing Beats the Microarray</title>
      <description><![CDATA[Sequencing after a negative CMA in a structurally abnormal fetus. As of this week you have a pooled number: twenty-seven percent incremental yield. Forty percent if the phenotype pointed you there before you ordered. Lim and colleagues, *Prenatal Diagnosis*, 2026.
And that number retires one question — whether sequencing is justified. The live question now is which fetuses bypass CMA entirely and go straight to sequencing. Harder problem. This paper doesn&apos;t fully...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=0">0:00</a> — Cold Open: The Clinical Question That Moved</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=51">0:52</a> — Headline: Clinical Question and Why a Meta-Analysis Earns the Grade</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=103">1:43</a> — Headline: Effect Size and the Pre-Selection Gradient</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=154">2:35</a> — Headline: Caveats — Heterogeneity and VUS</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=206">3:27</a> — Headline: Practice Impact</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=258">4:18</a> — Round 1: Stampalija / Single-Cell Trophoblast Sequencing</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=309">5:10</a> — Round 2: Cruz-Martínez / Latin American FETO</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=361">6:02</a> — Round 3: Sileo / Early TTTS Laser</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=413">6:53</a> — Round 4: Kim DeLuca / cfDNA and SCA Detection</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=464">7:45</a> — Close: What&apos;s Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1002/pd.70112">Diagnostic Yield of Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies: An Updated Systematic Review</a> - Provides pooled evidence for sequencing yield over CMA in structurally abnormal fetuses, directly informing when to offer exome or genome sequencing</li><li><a href="https://doi.org/10.1002/uog.70201">Single-cell-based non-invasive screening for fetal pathogenic microimbalances using maternal blood</a> - Demonstrates that single-cell trophoblast sequencing can detect submicroscopic CNVs non-invasively, potentially reducing need for amniocentesis</li><li><a href="https://doi.org/10.1002/pd.70175">Latin American Multicenter Study of Fetal Endoscopic Tracheal Occlusion for Severe Left Diaphragmatic Hernia</a> - Largest Latin American FETO dataset confirms survival benefit and extends outcome benchmarks beyond European and North American centers</li><li><a href="https://doi.org/10.1002/uog.70196">Perinatal outcomes of twin pregnancies complicated by early twin-to-twin transfusion syndrome treated with fetoscopic laser surgery</a> - Largest early-TTTS laser series provides stage-specific survival data for counseling families facing intervention before 18 weeks</li><li><a href="https://doi.org/10.1002/pd.70190">Impact of Prenatal Cell-Free DNA Screening on Sex Chromosome Aneuploidy Diagnoses in Infants and Children</a> - Population-level evidence that cfDNA screening has shifted SCA detection earlier, changing the timing and burden of counseling and subspecialty referral</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[Sequencing after a negative CMA in a structurally abnormal fetus. As of this week you have a pooled number: twenty-seven percent incremental yield. Forty percent if the phenotype pointed you there before you ordered. Lim and colleagues, *Prenatal Diagnosis*, 2026.
And that number retires one question — whether sequencing is justified. The live question now is which fetuses bypass CMA entirely and go straight to sequencing. Harder problem. This paper doesn&apos;t fully...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=0">0:00</a> — Cold Open: The Clinical Question That Moved</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=51">0:52</a> — Headline: Clinical Question and Why a Meta-Analysis Earns the Grade</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=103">1:43</a> — Headline: Effect Size and the Pre-Selection Gradient</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=154">2:35</a> — Headline: Caveats — Heterogeneity and VUS</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=206">3:27</a> — Headline: Practice Impact</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=258">4:18</a> — Round 1: Stampalija / Single-Cell Trophoblast Sequencing</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=309">5:10</a> — Round 2: Cruz-Martínez / Latin American FETO</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=361">6:02</a> — Round 3: Sileo / Early TTTS Laser</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=413">6:53</a> — Round 4: Kim DeLuca / cfDNA and SCA Detection</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3#t=464">7:45</a> — Close: What&apos;s Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1002/pd.70112">Diagnostic Yield of Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies: An Updated Systematic Review</a> - Provides pooled evidence for sequencing yield over CMA in structurally abnormal fetuses, directly informing when to offer exome or genome sequencing</li><li><a href="https://doi.org/10.1002/uog.70201">Single-cell-based non-invasive screening for fetal pathogenic microimbalances using maternal blood</a> - Demonstrates that single-cell trophoblast sequencing can detect submicroscopic CNVs non-invasively, potentially reducing need for amniocentesis</li><li><a href="https://doi.org/10.1002/pd.70175">Latin American Multicenter Study of Fetal Endoscopic Tracheal Occlusion for Severe Left Diaphragmatic Hernia</a> - Largest Latin American FETO dataset confirms survival benefit and extends outcome benchmarks beyond European and North American centers</li><li><a href="https://doi.org/10.1002/uog.70196">Perinatal outcomes of twin pregnancies complicated by early twin-to-twin transfusion syndrome treated with fetoscopic laser surgery</a> - Largest early-TTTS laser series provides stage-specific survival data for counseling families facing intervention before 18 weeks</li><li><a href="https://doi.org/10.1002/pd.70190">Impact of Prenatal Cell-Free DNA Screening on Sex Chromosome Aneuploidy Diagnoses in Infants and Children</a> - Population-level evidence that cfDNA screening has shifted SCA detection earlier, changing the timing and burden of counseling and subspecialty referral</li></ul><br><br><strong>Sources:</strong><ul><li>Lim et al. - Prenat Diagn - 2026 - Diagnostic Yield of Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies: An Updated Systematic Review (https://doi.org/10.1002/pd.70112)</li><li>Stampalija et al. - Ultrasound Obstet Gynecol - 2026 - Single-cell-based non-invasive screening for fetal pathogenic microimbalances using maternal blood (https://doi.org/10.1002/uog.70201)</li><li>Cruz-Martínez et al. - Prenat Diagn - 2026 - Latin American Multicenter Study of Fetal Endoscopic Tracheal Occlusion for Severe Left Diaphragmatic Hernia (https://doi.org/10.1002/pd.70175)</li><li>Sileo et al. - Ultrasound Obstet Gynecol - 2026 - Perinatal outcomes of twin pregnancies complicated by early twin-to-twin transfusion syndrome treated with fetoscopic laser surgery (https://doi.org/10.1002/uog.70196)</li><li>Kim DeLuca - Prenat Diagn - 2026 - Impact of Prenatal Cell-Free DNA Screening on Sex Chromosome Aneuploidy Diagnoses in Infants and Children (https://doi.org/10.1002/pd.70190)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Wed, 03 Jun 2026 05:49:27 +0000</pubDate>
      <guid isPermaLink="false">72865287a4127e4599151192bdee92f5041f15c5fc71868c5838ddf7f8fa22b1</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.mp3" length="13477972" type="audio/mpeg"/>
      <itunes:duration>9:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260603_004102_the_fetal_frontier_-_week_of_2026_06_03.chapters.json" type="application/json+chapters"/>
    </item>
    <item>
      <title>Validation Rigor Separates Signal From Noise</title>
      <description><![CDATA[ESCAPE-MeVO reported. Thrombectomy versus medical management in medium-vessel occlusion — the trial answered whether the procedure works. Ospel and colleagues have now gone back into the imaging and asked the harder question: can baseline CT, CTA, and perfusion characteristics tell us who it works for?
Which is where the next thrombectomy expansion argument lands. MeVO is already at the edge of what the evidence supports, and if imaging can stratify benefit, the...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=0">0:00</a> — Cold Open: What This Week&apos;s Headline Changes</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=52">0:53</a> — Headline: Citation, Design, and Why the RCT Backbone Matters</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=105">1:45</a> — Headline: Effect Sizes and Subgroup Interactions</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=157">2:38</a> — Headline: Practice Impact and the Honest Caveat</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=210">3:30</a> — Round 1: Maiter, Lung Cancer AI Head-to-Head</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=262">4:23</a> — Round 2: Bahl, Breast Tomosynthesis Slab Reconstruction</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=315">5:15</a> — Round 3: Zhang, Mamba Architecture pCR Prediction</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=367">6:08</a> — Round 4: Liu, Radiomics for CMS4 Colorectal Subtyping</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=420">7:01</a> — Close: Open Questions and Sign-Off</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1148/radiol.251769">Reperfusion Therapy in ESCAPE-MeVO Trial Participants: Imaging Characteristics and Clinical Outcomes</a> - RCT-anchored imaging subgroup analysis in MeVO stroke; informs thrombectomy patient selection</li><li><a href="https://doi.org/10.1148/radiol.252205">Independent Head-to-Head Comparison of Commercial Artificial Intelligence Devices for Lung Cancer Detection on Chest Radiographs</a> - Independent benchmarking of commercial AI tools; directly informs deployment decisions</li><li><a href="https://doi.org/10.1148/radiol.252685">Impact of AI-based Slab Reconstruction Technology on the Diagnostic Accuracy of Screening Digital Breast Tomosynthesis</a> - Workflow optimization in breast imaging screening with maintained diagnostic performance</li><li><a href="https://doi.org/10.1038/s41746-026-02849-2">Deep learning prediction of pathological complete response in breast cancer using Mamba architecture</a> - Multicenter external validation of pCR prediction; relevant to neoadjuvant treatment planning</li><li><a href="https://doi.org/10.1148/radiol.251719">Interpretable MRI-based Multiparametric Radiomics for Preoperative Prediction of CMS4 Colorectal Cancer</a> - Preoperative molecular subtyping could inform surgical and systemic therapy planning</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[ESCAPE-MeVO reported. Thrombectomy versus medical management in medium-vessel occlusion — the trial answered whether the procedure works. Ospel and colleagues have now gone back into the imaging and asked the harder question: can baseline CT, CTA, and perfusion characteristics tell us who it works for?
Which is where the next thrombectomy expansion argument lands. MeVO is already at the edge of what the evidence supports, and if imaging can stratify benefit, the...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=0">0:00</a> — Cold Open: What This Week&apos;s Headline Changes</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=52">0:53</a> — Headline: Citation, Design, and Why the RCT Backbone Matters</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=105">1:45</a> — Headline: Effect Sizes and Subgroup Interactions</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=157">2:38</a> — Headline: Practice Impact and the Honest Caveat</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=210">3:30</a> — Round 1: Maiter, Lung Cancer AI Head-to-Head</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=262">4:23</a> — Round 2: Bahl, Breast Tomosynthesis Slab Reconstruction</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=315">5:15</a> — Round 3: Zhang, Mamba Architecture pCR Prediction</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=367">6:08</a> — Round 4: Liu, Radiomics for CMS4 Colorectal Subtyping</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3#t=420">7:01</a> — Close: Open Questions and Sign-Off</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1148/radiol.251769">Reperfusion Therapy in ESCAPE-MeVO Trial Participants: Imaging Characteristics and Clinical Outcomes</a> - RCT-anchored imaging subgroup analysis in MeVO stroke; informs thrombectomy patient selection</li><li><a href="https://doi.org/10.1148/radiol.252205">Independent Head-to-Head Comparison of Commercial Artificial Intelligence Devices for Lung Cancer Detection on Chest Radiographs</a> - Independent benchmarking of commercial AI tools; directly informs deployment decisions</li><li><a href="https://doi.org/10.1148/radiol.252685">Impact of AI-based Slab Reconstruction Technology on the Diagnostic Accuracy of Screening Digital Breast Tomosynthesis</a> - Workflow optimization in breast imaging screening with maintained diagnostic performance</li><li><a href="https://doi.org/10.1038/s41746-026-02849-2">Deep learning prediction of pathological complete response in breast cancer using Mamba architecture</a> - Multicenter external validation of pCR prediction; relevant to neoadjuvant treatment planning</li><li><a href="https://doi.org/10.1148/radiol.251719">Interpretable MRI-based Multiparametric Radiomics for Preoperative Prediction of CMS4 Colorectal Cancer</a> - Preoperative molecular subtyping could inform surgical and systemic therapy planning</li></ul><br><br><strong>Sources:</strong><ul><li>Ospel et al. - Radiology - 2026 - Reperfusion Therapy in ESCAPE-MeVO Trial Participants: Imaging Characteristics and Clinical Outcomes (https://doi.org/10.1148/radiol.251769)</li><li>Maiter et al. - Radiology - 2026 - Independent Head-to-Head Comparison of Commercial Artificial Intelligence Devices for Lung Cancer Detection on Chest Radiographs (https://doi.org/10.1148/radiol.252205)</li><li>Bahl et al. - Radiology - 2026 - Impact of AI-based Slab Reconstruction Technology on the Diagnostic Accuracy of Screening Digital Breast Tomosynthesis (https://doi.org/10.1148/radiol.252685)</li><li>Zhang et al. - NPJ Digital Medicine - 2026 - Deep learning prediction of pathological complete response in breast cancer using Mamba architecture (https://doi.org/10.1038/s41746-026-02849-2)</li><li>Liu et al. - Radiology - 2026 - Interpretable MRI-based Multiparametric Radiomics for Preoperative Prediction of CMS4 Colorectal Cancer (https://doi.org/10.1148/radiol.251719)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Wed, 03 Jun 2026 05:58:49 +0000</pubDate>
      <guid isPermaLink="false">8fe782935698398b4308245f1ca4ea958c9c45234e4bb32c187b76d1fd7e7041</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.mp3" length="12436627" type="audio/mpeg"/>
      <itunes:duration>8:38</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260603_005046_signal_in_the_scan_-_week_of_2026_06_03.chapters.json" type="application/json+chapters"/>
    </item>
      <item>
      <title>Valacyclovir at Scale, Resolved FGR&apos;s Shadow</title>
      <description><![CDATA[This week&apos;s lead paper is a seven-year French national cohort on prenatal CMV screening and valacyclovir treatment. Vertical transmission rates dropped after 2020. The design can&apos;t prove the drug caused that. Both of those sentences matter before we go further.
The question has been sitting there since the supportive RCT data emerged around 2020. Does efficacy in trial conditions translate when you deploy across an entire healthcare system — different screening i...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=0">0:00</a> — COLD OPEN: What Changed This Week</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=50">0:51</a> — HEADLINE: Design and Population</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=101">1:42</a> — HEADLINE: Effect Size and the Causation Problem</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=152">2:33</a> — HEADLINE: Practice Impact and the Prior Coverage Note</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=203">3:23</a> — ROUND 1: Keller — Resolved Early FGR and Neonatal Morbidity</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=254">4:14</a> — ROUND 2: Hannoun — Anti-HLA Antibodies and FGR</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=305">5:05</a> — ROUND 3: Kabiri — Late Short Cervix and Progesterone (Affectionate Disagreement)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=355">5:56</a> — ROUND 4: Ambia — Breakthrough Eclampsia on Magnesium</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=406">6:47</a> — CLOSE: What to Watch, What&apos;s Still Open</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1002/uog.70223">Changing trends in prenatal screening and treatment of cytomegalovirus infection in France: 7-year national cohort study (2017-2023)</a> - First large-scale national validation that valacyclovir reduces vertical CMV transmission outside trial conditions</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102020">Neonatal morbidity following resolution of fetal growth restriction diagnosed at second-trimester anatomy ultrasound</a> - Challenges the assumption that growth normalization after early FGR confers normal neonatal outcomes</li><li><a href="https://doi.org/10.1016/j.ajog.2026.05.019">Anti-HLA Antibodies and Risk of Fetal Growth Restriction</a> - Provides mechanistic insight into immune-mediated unexplained FGR with population-level data</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102012">Vaginal progesterone and risk of preterm birth in asymptomatic women with short cervix diagnosed after 24 weeks of gestation</a> - Directly addresses a common clinical dilemma with sobering signal about late-window progesterone efficacy</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102022">Eclampsia despite magnesium sulfate prophylaxis</a> - Characterizes a clinically important failure-mode population and associated morbidity</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[This week&apos;s lead paper is a seven-year French national cohort on prenatal CMV screening and valacyclovir treatment. Vertical transmission rates dropped after 2020. The design can&apos;t prove the drug caused that. Both of those sentences matter before we go further.
The question has been sitting there since the supportive RCT data emerged around 2020. Does efficacy in trial conditions translate when you deploy across an entire healthcare system — different screening i...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=0">0:00</a> — COLD OPEN: What Changed This Week</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=50">0:51</a> — HEADLINE: Design and Population</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=101">1:42</a> — HEADLINE: Effect Size and the Causation Problem</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=152">2:33</a> — HEADLINE: Practice Impact and the Prior Coverage Note</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=203">3:23</a> — ROUND 1: Keller — Resolved Early FGR and Neonatal Morbidity</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=254">4:14</a> — ROUND 2: Hannoun — Anti-HLA Antibodies and FGR</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=305">5:05</a> — ROUND 3: Kabiri — Late Short Cervix and Progesterone (Affectionate Disagreement)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=355">5:56</a> — ROUND 4: Ambia — Breakthrough Eclampsia on Magnesium</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3#t=406">6:47</a> — CLOSE: What to Watch, What&apos;s Still Open</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1002/uog.70223">Changing trends in prenatal screening and treatment of cytomegalovirus infection in France: 7-year national cohort study (2017-2023)</a> - First large-scale national validation that valacyclovir reduces vertical CMV transmission outside trial conditions</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102020">Neonatal morbidity following resolution of fetal growth restriction diagnosed at second-trimester anatomy ultrasound</a> - Challenges the assumption that growth normalization after early FGR confers normal neonatal outcomes</li><li><a href="https://doi.org/10.1016/j.ajog.2026.05.019">Anti-HLA Antibodies and Risk of Fetal Growth Restriction</a> - Provides mechanistic insight into immune-mediated unexplained FGR with population-level data</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102012">Vaginal progesterone and risk of preterm birth in asymptomatic women with short cervix diagnosed after 24 weeks of gestation</a> - Directly addresses a common clinical dilemma with sobering signal about late-window progesterone efficacy</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102022">Eclampsia despite magnesium sulfate prophylaxis</a> - Characterizes a clinically important failure-mode population and associated morbidity</li></ul><br><br><strong>Sources:</strong><ul><li>Coste-Mazeau et al. - Ultrasound Obstet Gynecol - 2026 - Changing trends in prenatal screening and treatment of cytomegalovirus infection in France: 7-year national cohort study (2017-2023) (https://doi.org/10.1002/uog.70223)</li><li>Keller et al. - Am J Obstet Gynecol MFM - 2026 - Neonatal morbidity following resolution of fetal growth restriction diagnosed at second-trimester anatomy ultrasound (https://doi.org/10.1016/j.ajogmf.2026.102020)</li><li>Hannoun et al. - Am J Obstet Gynecol - 2026 - Anti-HLA Antibodies and Risk of Fetal Growth Restriction (https://doi.org/10.1016/j.ajog.2026.05.019)</li><li>Kabiri et al. - Am J Obstet Gynecol MFM - 2026 - Vaginal progesterone and risk of preterm birth in asymptomatic women with short cervix diagnosed after 24 weeks of gestation (https://doi.org/10.1016/j.ajogmf.2026.102012)</li><li>Ambia et al. - Am J Obstet Gynecol MFM - 2026 - Eclampsia despite magnesium sulfate prophylaxis (https://doi.org/10.1016/j.ajogmf.2026.102022)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Tue, 09 Jun 2026 10:08:54 +0000</pubDate>
      <guid isPermaLink="false">4f113afcc2eb042c8456423dc798d8361373728644ab05c199450341254cbdb8</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.mp3" length="12064852" type="audio/mpeg"/>
      <itunes:duration>8:23</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260609_050148_mfm_rounds_-_week_of_2026_06_09.chapters.json" type="application/json+chapters"/>
    </item>
      <item>
      <title>Hemodynamic Phenotypes Before Blood Pressure Numbers</title>
      <description><![CDATA[We have been selecting antihypertensives in HDP based on the number on the cuff. Labetalol or nifedipine, triggered by threshold. Novelli&apos;s meta-analysis this week asks whether the hemodynamic phenotype behind that number — high cardiac output versus high vascular resistance — should determine which drug you reach for, and whether outcomes follow when you make that distinction.
From Ultrasound in Obstetrics and Gynecology, 2026: Novelli and colleagues, a systema...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=0">0:00</a> — Cold Open: The Clinical Problem</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=38">0:38</a> — Headline: Design and Clinical Question</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=76">1:17</a> — Headline: Effect Size and the Heterogeneity Problem</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=114">1:55</a> — Headline: Practice Impact and What Tertiary Centers Can Do Now</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=153">2:33</a> — Pivot and Round 1: Baucom, Twin Chorionicity and Maternal Morbidity</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=191">3:11</a> — Round 2: Houri, Preeclampsia Phenotyping</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=229">3:50</a> — Round 3: Miodownik, Placental Syndromes and Long-Term Risk</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=268">4:28</a> — Round 4: Huynh, Vasa Previa Hospitalization Guidelines</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=306">5:06</a> — Close: What to Watch, What Is Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1002/uog.70250">Hemodynamics-guided treatment of hypertensive disorders of pregnancy: systematic review and meta-analysis</a> - Meta-analysis of RCTs showing hemodynamics-guided antihypertensive management reduces composite adverse outcomes versus BP-threshold-only care — potentially practice-changing for HDP treatment</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.101993">Severe maternal morbidity and obstetrical outcomes by twin chorionicity and amnionicity</a> - Large national database quantifying substantially higher severe maternal morbidity in MCDA and MCMA twins versus dichorionic or singleton gestations</li><li><a href="https://doi.org/10.1111/1471-0528.70262">Phenotyping Preeclampsia Using Unsupervised Machine Learning: A Prospective Cohort Study</a> - Identifies three clinically distinct preeclampsia phenotypes with different severity, angiogenic profiles, and delivery timing — hypothesis-generating for individualized management</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102008">Expert Review: Pregnancy Placental Syndromes and the Effects on Long-Term Health</a> - Synthesizes evidence that placental syndromes predict long-term cardiovascular, renal, and metabolic risk — actionable for postpartum counseling and surveillance</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102017">Hospitalization for Vasa Previa: a Review of National Guidelines</a> - Reveals inconsistent international guidelines on antenatal hospitalization for vasa previa, clarifying that current practice rests on weak evidence</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[We have been selecting antihypertensives in HDP based on the number on the cuff. Labetalol or nifedipine, triggered by threshold. Novelli&apos;s meta-analysis this week asks whether the hemodynamic phenotype behind that number — high cardiac output versus high vascular resistance — should determine which drug you reach for, and whether outcomes follow when you make that distinction.
From Ultrasound in Obstetrics and Gynecology, 2026: Novelli and colleagues, a systema...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=0">0:00</a> — Cold Open: The Clinical Problem</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=38">0:38</a> — Headline: Design and Clinical Question</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=76">1:17</a> — Headline: Effect Size and the Heterogeneity Problem</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=114">1:55</a> — Headline: Practice Impact and What Tertiary Centers Can Do Now</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=153">2:33</a> — Pivot and Round 1: Baucom, Twin Chorionicity and Maternal Morbidity</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=191">3:11</a> — Round 2: Houri, Preeclampsia Phenotyping</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=229">3:50</a> — Round 3: Miodownik, Placental Syndromes and Long-Term Risk</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=268">4:28</a> — Round 4: Huynh, Vasa Previa Hospitalization Guidelines</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3#t=306">5:06</a> — Close: What to Watch, What Is Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1002/uog.70250">Hemodynamics-guided treatment of hypertensive disorders of pregnancy: systematic review and meta-analysis</a> - Meta-analysis of RCTs showing hemodynamics-guided antihypertensive management reduces composite adverse outcomes versus BP-threshold-only care — potentially practice-changing for HDP treatment</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.101993">Severe maternal morbidity and obstetrical outcomes by twin chorionicity and amnionicity</a> - Large national database quantifying substantially higher severe maternal morbidity in MCDA and MCMA twins versus dichorionic or singleton gestations</li><li><a href="https://doi.org/10.1111/1471-0528.70262">Phenotyping Preeclampsia Using Unsupervised Machine Learning: A Prospective Cohort Study</a> - Identifies three clinically distinct preeclampsia phenotypes with different severity, angiogenic profiles, and delivery timing — hypothesis-generating for individualized management</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102008">Expert Review: Pregnancy Placental Syndromes and the Effects on Long-Term Health</a> - Synthesizes evidence that placental syndromes predict long-term cardiovascular, renal, and metabolic risk — actionable for postpartum counseling and surveillance</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102017">Hospitalization for Vasa Previa: a Review of National Guidelines</a> - Reveals inconsistent international guidelines on antenatal hospitalization for vasa previa, clarifying that current practice rests on weak evidence</li></ul><br><br><strong>Sources:</strong><ul><li>Novelli et al. - Ultrasound Obstet Gynecol - 2026 - Hemodynamics-guided treatment of hypertensive disorders of pregnancy: systematic review and meta-analysis (https://doi.org/10.1002/uog.70250)</li><li>Baucom et al. - Am J Obstet Gynecol MFM - 2026 - Severe maternal morbidity and obstetrical outcomes by twin chorionicity and amnionicity (https://doi.org/10.1016/j.ajogmf.2026.101993)</li><li>Houri et al. - BJOG - 2026 - Phenotyping Preeclampsia Using Unsupervised Machine Learning: A Prospective Cohort Study (https://doi.org/10.1111/1471-0528.70262)</li><li>Miodownik et al. - Am J Obstet Gynecol MFM - 2026 - Expert Review: Pregnancy Placental Syndromes and the Effects on Long-Term Health (https://doi.org/10.1016/j.ajogmf.2026.102008)</li><li>Huynh et al. - Am J Obstet Gynecol MFM - 2026 - Hospitalization for Vasa Previa: a Review of National Guidelines (https://doi.org/10.1016/j.ajogmf.2026.102017)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Mon, 15 Jun 2026 10:08:20 +0000</pubDate>
      <guid isPermaLink="false">db51f624e3f39792c0a9ec568fc01d2b32f1743002ba7b4fc73cfded2e5ee55a</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.mp3" length="9353342" type="audio/mpeg"/>
      <itunes:duration>6:30</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260615_050140_mfm_rounds_-_week_of_2026_06_15.chapters.json" type="application/json+chapters"/>
    </item>
      <item>
      <title>RSV Vaccine Safety at Scale</title>
      <description><![CDATA[RSVpreF has been recommended at thirty-two to thirty-six weeks since 2023. That window was set partly in response to a preterm birth signal in the RENOIR prelicensure trial — a signal that didn&apos;t replicate consistently across all prelicensure data but was real enough that ACIP acted on it. Post-licensure obstetric safety at scale has been uncharacterized. That changes this week.
Four outcomes. Two years of counseling on incomplete data.
From O...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=0">0:00</a> — Cold Open</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=40">0:41</a> — Headline: Citation and Design</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=81">1:22</a> — Headline: The Result</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=122">2:02</a> — Headline: Limitations and Practice Impact</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=163">2:43</a> — Pivot</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=204">3:24</a> — Round 1: Larrea (Balloon Tamponade Duration)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=244">4:05</a> — Round 2: Schenone (IUT for Tumor-Related Fetal Anemia)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=285">4:46</a> — Round 3: Prasad (Preeclampsia Phenotyping)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=326">5:26</a> — Round 4: Yun (HOMA-IR and PCOS Fertility Outcomes)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=367">6:07</a> — Close: What to Watch / Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1097/aog.0000000000006354">Association of Respiratory Syncytial Virus Vaccination During Pregnancy With Adverse Obstetric and Neonatal Outcomes</a> - Largest post-licensure safety study of RSVpreF in pregnancy; no signal for PTB, stillbirth, SGA, or HDP at recommended gestational window</li><li><a href="https://doi.org/10.1097/aog.0000000000006295">Intrauterine Balloon Tamponade Duration for Postpartum Hemorrhage: A Randomized Controlled Trial</a> - First RCT comparing balloon tamponade durations; may shorten standard dwell time if noninferiority confirmed</li><li><a href="https://doi.org/10.1002/uog.70234">Perinatal outcomes following intrauterine transfusion for fetal anemia secondary to fetal or placental tumor: systematic review</a> - Aggregates rare-condition outcome data for IUT in tumor-related fetal anemia; useful for counseling despite limited case numbers</li><li><a href="https://doi.org/10.1111/1471-0528.70289">Pre-Eclampsia Beyond the Binary: Rethinking Phenotypes for Clinical Use</a> - Conceptual framework for preeclampsia phenotyping; may shape future research and guideline development</li><li><a href="https://doi.org/10.1097/aog.0000000000006318">Prepregnancy Insulin Resistance and Fertility and Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome</a> - HOMA-IR as preconception predictor of fertility outcomes in PCOS; actionable for risk stratification</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[RSVpreF has been recommended at thirty-two to thirty-six weeks since 2023. That window was set partly in response to a preterm birth signal in the RENOIR prelicensure trial — a signal that didn&apos;t replicate consistently across all prelicensure data but was real enough that ACIP acted on it. Post-licensure obstetric safety at scale has been uncharacterized. That changes this week.
Four outcomes. Two years of counseling on incomplete data.
From O...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=0">0:00</a> — Cold Open</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=40">0:41</a> — Headline: Citation and Design</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=81">1:22</a> — Headline: The Result</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=122">2:02</a> — Headline: Limitations and Practice Impact</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=163">2:43</a> — Pivot</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=204">3:24</a> — Round 1: Larrea (Balloon Tamponade Duration)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=244">4:05</a> — Round 2: Schenone (IUT for Tumor-Related Fetal Anemia)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=285">4:46</a> — Round 3: Prasad (Preeclampsia Phenotyping)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=326">5:26</a> — Round 4: Yun (HOMA-IR and PCOS Fertility Outcomes)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3#t=367">6:07</a> — Close: What to Watch / Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1097/aog.0000000000006354">Association of Respiratory Syncytial Virus Vaccination During Pregnancy With Adverse Obstetric and Neonatal Outcomes</a> - Largest post-licensure safety study of RSVpreF in pregnancy; no signal for PTB, stillbirth, SGA, or HDP at recommended gestational window</li><li><a href="https://doi.org/10.1097/aog.0000000000006295">Intrauterine Balloon Tamponade Duration for Postpartum Hemorrhage: A Randomized Controlled Trial</a> - First RCT comparing balloon tamponade durations; may shorten standard dwell time if noninferiority confirmed</li><li><a href="https://doi.org/10.1002/uog.70234">Perinatal outcomes following intrauterine transfusion for fetal anemia secondary to fetal or placental tumor: systematic review</a> - Aggregates rare-condition outcome data for IUT in tumor-related fetal anemia; useful for counseling despite limited case numbers</li><li><a href="https://doi.org/10.1111/1471-0528.70289">Pre-Eclampsia Beyond the Binary: Rethinking Phenotypes for Clinical Use</a> - Conceptual framework for preeclampsia phenotyping; may shape future research and guideline development</li><li><a href="https://doi.org/10.1097/aog.0000000000006318">Prepregnancy Insulin Resistance and Fertility and Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome</a> - HOMA-IR as preconception predictor of fertility outcomes in PCOS; actionable for risk stratification</li></ul><br><br><strong>Sources:</strong><ul><li>DeSilva et al. - Obstet Gynecol - 2026 - Association of Respiratory Syncytial Virus Vaccination During Pregnancy With Adverse Obstetric and Neonatal Outcomes (https://doi.org/10.1097/aog.0000000000006354)</li><li>Larrea et al. - Obstet Gynecol - 2026 - Intrauterine Balloon Tamponade Duration for Postpartum Hemorrhage: A Randomized Controlled Trial (https://doi.org/10.1097/aog.0000000000006295)</li><li>Schenone et al. - Ultrasound Obstet Gynecol - 2026 - Perinatal outcomes following intrauterine transfusion for fetal anemia secondary to fetal or placental tumor: systematic review (https://doi.org/10.1002/uog.70234)</li><li>Prasad et al. - BJOG - 2026 - Pre-Eclampsia Beyond the Binary: Rethinking Phenotypes for Clinical Use (https://doi.org/10.1111/1471-0528.70289)</li><li>Yun et al. - Obstet Gynecol - 2026 - Prepregnancy Insulin Resistance and Fertility and Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome (https://doi.org/10.1097/aog.0000000000006318)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Mon, 22 Jun 2026 10:16:49 +0000</pubDate>
      <guid isPermaLink="false">e94533aa5610a387d44494b184604bb48087be857cc5745b14e39dbd12b7b8ca</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.mp3" length="10874297" type="audio/mpeg"/>
      <itunes:duration>7:33</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260622_050158_mfm_rounds_-_week_of_2026_06_22.chapters.json" type="application/json+chapters"/>
    </item>
      <item>
      <title>Stillbirth Recurrence Beyond the First Cause</title>
      <description><![CDATA[Every post-stillbirth consult has the same question underneath it: is the recurrence risk coming from whatever caused the first loss, or does the history itself carry independent weight? Henricks asks whether that&apos;s the whole story. Based on this cohort, the answer appears to be no.
And if the history adds something independent, you&apos;re having a different conversation at the preconception visit even when the workup comes back clean.
Right. The d...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=0">0:00</a> — Cold Open: The Clinical Question</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=47">0:47</a> — Headline: Citation and Design</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=94">1:35</a> — Headline: Effect Size and What It Means</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=141">2:22</a> — Headline: Caveat and Practice Impact</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=189">3:09</a> — Round 1: Rondagh — Monochorionic Twins and Anastomosis Burden</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=236">3:56</a> — Round 2: Champion — AC Extremes in Pregestational Diabetes</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=283">4:44</a> — Round 3: Mei-Dan — Spontaneous PTB as Cardiovascular Risk Marker</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=331">5:31</a> — Round 4: Tersigni — Pre-Cerclage Amniocentesis</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=378">6:18</a> — Close: What Remains Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1016/j.ajog.2026.06.010">Prior Stillbirth is Associated with Increased Risk of Subsequent Stillbirth</a> - Establishes that prior stillbirth independently elevates recurrence risk, directly informing surveillance intensity and preconception counseling</li><li><a href="https://doi.org/10.1016/j.ajog.2026.06.016">The Role of Placental Anastomoses in Severe Brain Injury After Fetal Demise in Monochorionic Twins</a> - Quantifies the relationship between anastomosis patterns and survivor brain injury, guiding post-demise counseling and imaging timing</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102042">Fetal abdominal circumference and adverse perinatal outcomes in pregnant individuals with pregestational diabetes</a> - Defines clinical utility of AC extremes in pregestational diabetes for identifying fetuses at elevated perinatal risk</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102019">Preterm birth as a risk factor for future maternal cardiovascular morbidity</a> - Supports incorporating spontaneous PTB history into long-term maternal cardiovascular risk assessment</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102014">Amniocentesis before cerclage in asymptomatic women with mid-trimester short cervix: time to consider?</a> - Proposes a framework to distinguish mechanical from inflammatory cervical insufficiency before cerclage placement</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[Every post-stillbirth consult has the same question underneath it: is the recurrence risk coming from whatever caused the first loss, or does the history itself carry independent weight? Henricks asks whether that&apos;s the whole story. Based on this cohort, the answer appears to be no.
And if the history adds something independent, you&apos;re having a different conversation at the preconception visit even when the workup comes back clean.
Right. The d...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=0">0:00</a> — Cold Open: The Clinical Question</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=47">0:47</a> — Headline: Citation and Design</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=94">1:35</a> — Headline: Effect Size and What It Means</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=141">2:22</a> — Headline: Caveat and Practice Impact</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=189">3:09</a> — Round 1: Rondagh — Monochorionic Twins and Anastomosis Burden</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=236">3:56</a> — Round 2: Champion — AC Extremes in Pregestational Diabetes</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=283">4:44</a> — Round 3: Mei-Dan — Spontaneous PTB as Cardiovascular Risk Marker</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=331">5:31</a> — Round 4: Tersigni — Pre-Cerclage Amniocentesis</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3#t=378">6:18</a> — Close: What Remains Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1016/j.ajog.2026.06.010">Prior Stillbirth is Associated with Increased Risk of Subsequent Stillbirth</a> - Establishes that prior stillbirth independently elevates recurrence risk, directly informing surveillance intensity and preconception counseling</li><li><a href="https://doi.org/10.1016/j.ajog.2026.06.016">The Role of Placental Anastomoses in Severe Brain Injury After Fetal Demise in Monochorionic Twins</a> - Quantifies the relationship between anastomosis patterns and survivor brain injury, guiding post-demise counseling and imaging timing</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102042">Fetal abdominal circumference and adverse perinatal outcomes in pregnant individuals with pregestational diabetes</a> - Defines clinical utility of AC extremes in pregestational diabetes for identifying fetuses at elevated perinatal risk</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102019">Preterm birth as a risk factor for future maternal cardiovascular morbidity</a> - Supports incorporating spontaneous PTB history into long-term maternal cardiovascular risk assessment</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102014">Amniocentesis before cerclage in asymptomatic women with mid-trimester short cervix: time to consider?</a> - Proposes a framework to distinguish mechanical from inflammatory cervical insufficiency before cerclage placement</li></ul><br><br><strong>Sources:</strong><ul><li>Henricks et al. - Am J Obstet Gynecol - 2026 - Prior Stillbirth is Associated with Increased Risk of Subsequent Stillbirth (https://doi.org/10.1016/j.ajog.2026.06.010)</li><li>Rondagh et al. - Am J Obstet Gynecol - 2026 - The Role of Placental Anastomoses in Severe Brain Injury After Fetal Demise in Monochorionic Twins (https://doi.org/10.1016/j.ajog.2026.06.016)</li><li>Champion et al. - Am J Obstet Gynecol MFM - 2026 - Fetal abdominal circumference and adverse perinatal outcomes in pregnant individuals with pregestational diabetes (https://doi.org/10.1016/j.ajogmf.2026.102042)</li><li>Mei-Dan et al. - Am J Obstet Gynecol MFM - 2026 - Preterm birth as a risk factor for future maternal cardiovascular morbidity (https://doi.org/10.1016/j.ajogmf.2026.102019)</li><li>Tersigni et al. - Am J Obstet Gynecol MFM - 2026 - Amniocentesis before cerclage in asymptomatic women with mid-trimester short cervix: time to consider? (https://doi.org/10.1016/j.ajogmf.2026.102014)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Mon, 29 Jun 2026 10:21:03 +0000</pubDate>
      <guid isPermaLink="false">2a134db307c6007b4f00658fe94156e13115fac6ab00741a6f1f9a16ef0d38f8</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.mp3" length="11296226" type="audio/mpeg"/>
      <itunes:duration>7:51</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260629_050238_mfm_rounds_-_week_of_2026_06_29.chapters.json" type="application/json+chapters"/>
    </item>
      <item>
      <title>Hattler&apos;s 187,000</title>
      <description><![CDATA[The question every MFM is fielding right now: a patient presents at eight weeks, conceived on semaglutide, discontinued at five or six weeks. What&apos;s the maternal risk sentence? Until this week, the honest answer had a specific gap — no large-N synthesis of post-licensure maternal outcomes. That gap is now partially closed.
Partially. The scope is specific, and both facts have to travel together.
From Obstetrics and Gynecology, 2026: Hattler and...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=0">0:00</a> — Cold Open: The Counseling Sentence That Changed</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=44">0:44</a> — Headline: Study Identity and Design Rationale</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=88">1:28</a> — Headline: The Finding and What the Numbers Actually Say</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=132">2:12</a> — Headline: Practice Impact and the Fetal Outcome Gap</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=176">2:56</a> — Pivot + Round 1: Spinillo CP Umbrella Review</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=220">3:40</a> — Round 2: Boelig Cerclage Meta-Analysis</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=264">4:25</a> — Round 3: Ani Cost-Effectiveness Analysis</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=308">5:09</a> — Round 4: Moon-Grady Fetal Cardiac Intervention in Hydrops</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=352">5:53</a> — Close: What Remains Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1097/aog.0000000000006363">Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis</a> - First large-scale meta-analysis addressing maternal safety of GLP-1 RAs in pregnancy; directly relevant to preconception counseling as prescribing expands</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.101990">Antenatal, pregnancy and delivery risk factors for infant cerebral palsy: an umbrella review of meta-analyses and systematic reviews</a> - Comprehensive synthesis of 43 CP risk factors with evidence grading; useful reference for structured counseling</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102048">Outcomes with cerclage for short cervix ≤20.9mm before 24 weeks in singletons without prior preterm birth: a focused meta-analysis of randomized controlled trials</a> - Directly addresses a contested clinical indication using RCT-level evidence; informs shared decision-making</li><li><a href="https://doi.org/10.1111/1471-0528.70294">First Trimester Screening for Preterm Preeclampsia in the United Kingdom: A Cost-Effectiveness Analysis</a> - Provides health-economic justification for FMF screening adoption at policy level</li><li><a href="https://doi.org/10.1002/uog.70245">Invasive in-utero cardiac intervention in the hydropic fetus may improve survival: results from the International Fetal Cardiac Intervention Registry (IFCIR)</a> - Largest multicenter dataset on fetal cardiac intervention in hydrops; informs case selection at specialized centers</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[The question every MFM is fielding right now: a patient presents at eight weeks, conceived on semaglutide, discontinued at five or six weeks. What&apos;s the maternal risk sentence? Until this week, the honest answer had a specific gap — no large-N synthesis of post-licensure maternal outcomes. That gap is now partially closed.
Partially. The scope is specific, and both facts have to travel together.
From Obstetrics and Gynecology, 2026: Hattler and...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=0">0:00</a> — Cold Open: The Counseling Sentence That Changed</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=44">0:44</a> — Headline: Study Identity and Design Rationale</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=88">1:28</a> — Headline: The Finding and What the Numbers Actually Say</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=132">2:12</a> — Headline: Practice Impact and the Fetal Outcome Gap</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=176">2:56</a> — Pivot + Round 1: Spinillo CP Umbrella Review</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=220">3:40</a> — Round 2: Boelig Cerclage Meta-Analysis</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=264">4:25</a> — Round 3: Ani Cost-Effectiveness Analysis</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=308">5:09</a> — Round 4: Moon-Grady Fetal Cardiac Intervention in Hydrops</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3#t=352">5:53</a> — Close: What Remains Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1097/aog.0000000000006363">Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis</a> - First large-scale meta-analysis addressing maternal safety of GLP-1 RAs in pregnancy; directly relevant to preconception counseling as prescribing expands</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.101990">Antenatal, pregnancy and delivery risk factors for infant cerebral palsy: an umbrella review of meta-analyses and systematic reviews</a> - Comprehensive synthesis of 43 CP risk factors with evidence grading; useful reference for structured counseling</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102048">Outcomes with cerclage for short cervix ≤20.9mm before 24 weeks in singletons without prior preterm birth: a focused meta-analysis of randomized controlled trials</a> - Directly addresses a contested clinical indication using RCT-level evidence; informs shared decision-making</li><li><a href="https://doi.org/10.1111/1471-0528.70294">First Trimester Screening for Preterm Preeclampsia in the United Kingdom: A Cost-Effectiveness Analysis</a> - Provides health-economic justification for FMF screening adoption at policy level</li><li><a href="https://doi.org/10.1002/uog.70245">Invasive in-utero cardiac intervention in the hydropic fetus may improve survival: results from the International Fetal Cardiac Intervention Registry (IFCIR)</a> - Largest multicenter dataset on fetal cardiac intervention in hydrops; informs case selection at specialized centers</li></ul><br><br><strong>Sources:</strong><ul><li>Hattler et al. - Obstet Gynecol - 2026 - Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis (https://doi.org/10.1097/aog.0000000000006363)</li><li>Spinillo et al. - Am J Obstet Gynecol MFM - 2026 - Antenatal, pregnancy and delivery risk factors for infant cerebral palsy: an umbrella review of meta-analyses and systematic reviews (https://doi.org/10.1016/j.ajogmf.2026.101990)</li><li>Boelig et al. - Am J Obstet Gynecol MFM - 2026 - Outcomes with cerclage for short cervix ≤20.9mm before 24 weeks in singletons without prior preterm birth: a focused meta-analysis of randomized controlled trials (https://doi.org/10.1016/j.ajogmf.2026.102048)</li><li>Ani et al. - BJOG - 2026 - First Trimester Screening for Preterm Preeclampsia in the United Kingdom: A Cost-Effectiveness Analysis (https://doi.org/10.1111/1471-0528.70294)</li><li>Moon-Grady et al. - Ultrasound Obstet Gynecol - 2026 - Invasive in-utero cardiac intervention in the hydropic fetus may improve survival: results from the International Fetal Cardiac Intervention Registry (IFCIR) (https://doi.org/10.1002/uog.70245)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Tue, 07 Jul 2026 10:17:35 +0000</pubDate>
      <guid isPermaLink="false">0d78957d4617ceebfc9f194054b71aa3ae458d12bb92e80570ba575860e0271f</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.mp3" length="10604086" type="audio/mpeg"/>
      <itunes:duration>7:22</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260707_050300_mfm_rounds_-_week_of_2026_07_07.chapters.json" type="application/json+chapters"/>
    </item>
      <item>
      <title>The First Cerclage Trial</title>
      <description><![CDATA[Emergency cerclage technique has been decided by operator preference since the procedure entered practice. This week it has a randomized trial. Seven centers, head-to-head, double versus single, both arms on vaginal progesterone. That&apos;s the lead.
First time that comparison has randomized data behind it.
First time.
From AJOG, 2026: Kosińska-Kaczyńska and colleagues, a multicenter non-blinded RCT across 7 tertiary centers — doubl...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=0">0:00</a> — Cold Open: The Question That Needed a Trial</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=44">0:45</a> — Headline: Citation, Design, and What Earns the Evidence Grade</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=89">1:29</a> — Headline: Effect in Numbers, Then the Caveat</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=133">2:14</a> — Headline: Practice Impact, Honest Version</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=178">2:59</a> — Round 1: Lithium in Pregnancy (Roddy Mitchell)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=223">3:43</a> — Round 2: Ischemic Placental Disease and Postpartum Brain Morbidity (Ananth)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=267">4:28</a> — Round 3: Severe Preeclampsia Features and Morbidity Risk (Meng)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=312">5:12</a> — Round 4: Hadlock Internal Inconsistency (Adu-Bredu)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=357">5:57</a> — Close: What to Watch, What Is Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1016/j.ajog.2026.07.004">Double versus single emergency cervical cerclage combined with vaginal progesterone: a multicenter, non-blinded, randomized controlled trial</a> - First RCT directly comparing cerclage techniques in the emergency setting; informs whether double-level placement justifies added complexity</li><li><a href="https://doi.org/10.1111/1471-0528.70301">Lithium Use in Pregnancy and the Risk of Spontaneous Preterm Birth: An Australian Statewide Retrospective Cohort Study</a> - Large population cohort quantifying lithium-associated risks; directly actionable for preconception counseling in bipolar patients</li><li><a href="https://doi.org/10.1016/j.ajog.2026.07.008">Ischemic Placental Disease and Hospitalization for Neurological and Psychiatric Disorders</a> - Highlights maternal brain as target organ of placental dysfunction; supports enhanced postpartum surveillance after severe placental syndromes</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102052">Associations between individual severe features of preeclampsia and severe maternal morbidity</a> - Differentiates risk by specific severe feature; supports moving beyond binary classification toward feature-specific counseling</li><li><a href="https://doi.org/10.1111/1471-0528.70296">Internal Consistency of the Hadlock Estimated Fetal Weight Reference: Methodological Analysis</a> - Identifies systematic discrepancies in widely-used reference at clinically critical thresholds; affects SGA classification decisions</li></ul><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.companion.json">Episode companion data</a>]]></description>
      <content:encoded><![CDATA[Emergency cerclage technique has been decided by operator preference since the procedure entered practice. This week it has a randomized trial. Seven centers, head-to-head, double versus single, both arms on vaginal progesterone. That&apos;s the lead.
First time that comparison has randomized data behind it.
First time.
From AJOG, 2026: Kosińska-Kaczyńska and colleagues, a multicenter non-blinded RCT across 7 tertiary centers — doubl...<br><br><em>Juno, Caspar, and any guest voices are AI-generated. Episode text and audio are generated with human-directed software.</em><br><br><strong>Chapters:</strong><ol><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=0">0:00</a> — Cold Open: The Question That Needed a Trial</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=44">0:45</a> — Headline: Citation, Design, and What Earns the Evidence Grade</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=89">1:29</a> — Headline: Effect in Numbers, Then the Caveat</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=133">2:14</a> — Headline: Practice Impact, Honest Version</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=178">2:59</a> — Round 1: Lithium in Pregnancy (Roddy Mitchell)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=223">3:43</a> — Round 2: Ischemic Placental Disease and Postpartum Brain Morbidity (Ananth)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=267">4:28</a> — Round 3: Severe Preeclampsia Features and Morbidity Risk (Meng)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=312">5:12</a> — Round 4: Hadlock Internal Inconsistency (Adu-Bredu)</li><li><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3#t=357">5:57</a> — Close: What to Watch, What Is Still Unsettled</li></ol><br><br><strong>Follow-up links:</strong><ul><li><a href="https://doi.org/10.1016/j.ajog.2026.07.004">Double versus single emergency cervical cerclage combined with vaginal progesterone: a multicenter, non-blinded, randomized controlled trial</a> - First RCT directly comparing cerclage techniques in the emergency setting; informs whether double-level placement justifies added complexity</li><li><a href="https://doi.org/10.1111/1471-0528.70301">Lithium Use in Pregnancy and the Risk of Spontaneous Preterm Birth: An Australian Statewide Retrospective Cohort Study</a> - Large population cohort quantifying lithium-associated risks; directly actionable for preconception counseling in bipolar patients</li><li><a href="https://doi.org/10.1016/j.ajog.2026.07.008">Ischemic Placental Disease and Hospitalization for Neurological and Psychiatric Disorders</a> - Highlights maternal brain as target organ of placental dysfunction; supports enhanced postpartum surveillance after severe placental syndromes</li><li><a href="https://doi.org/10.1016/j.ajogmf.2026.102052">Associations between individual severe features of preeclampsia and severe maternal morbidity</a> - Differentiates risk by specific severe feature; supports moving beyond binary classification toward feature-specific counseling</li><li><a href="https://doi.org/10.1111/1471-0528.70296">Internal Consistency of the Hadlock Estimated Fetal Weight Reference: Methodological Analysis</a> - Identifies systematic discrepancies in widely-used reference at clinically critical thresholds; affects SGA classification decisions</li></ul><br><br><strong>Sources:</strong><ul><li>Kosińska-Kaczyńska et al. - Am J Obstet Gynecol - 2026 - Double versus single emergency cervical cerclage combined with vaginal progesterone: a multicenter, non-blinded, randomized controlled trial (https://doi.org/10.1016/j.ajog.2026.07.004)</li><li>Roddy Mitchell - BJOG - 2026 - Lithium Use in Pregnancy and the Risk of Spontaneous Preterm Birth: An Australian Statewide Retrospective Cohort Study (https://doi.org/10.1111/1471-0528.70301)</li><li>Ananth et al. - Am J Obstet Gynecol - 2026 - Ischemic Placental Disease and Hospitalization for Neurological and Psychiatric Disorders (https://doi.org/10.1016/j.ajog.2026.07.008)</li><li>Meng et al. - Am J Obstet Gynecol MFM - 2026 - Associations between individual severe features of preeclampsia and severe maternal morbidity (https://doi.org/10.1016/j.ajogmf.2026.102052)</li><li>Adu-Bredu et al. - BJOG - 2026 - Internal Consistency of the Hadlock Estimated Fetal Weight Reference: Methodological Analysis (https://doi.org/10.1111/1471-0528.70296)</li></ul><br><em>Original synthetic theme music generated locally for this episode.</em><br><br><a href="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.companion.json">Episode companion data</a>]]></content:encoded>
      <pubDate>Tue, 14 Jul 2026 10:17:25 +0000</pubDate>
      <guid isPermaLink="false">d23cdd5e3f4b3657b0e88b0872ba388e7c4de048f67c32dfa7198a945fb5b284</guid>
      <enclosure url="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.mp3" length="10723204" type="audio/mpeg"/>
      <itunes:duration>7:27</itunes:duration>
      <itunes:explicit>false</itunes:explicit>
      <podcast:chapters url="https://rauscha.github.io/Dialog-podcast/episodes/20260714_050223_mfm_rounds_-_week_of_2026_07_14.chapters.json" type="application/json+chapters"/>
    </item>
  </channel>
</rss>